Search Results

• • 47 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections

  Authors:Jessica Cottreau, Shannon F Baker, Herbert L DuPont, and Kevin W GareyFrom:Expert Review of Anti-infective Therapy (Vol. 8, Issue 7) Peer-Reviewed

  July 20109,355 words Report 1360LAuthor(s): Jessica Cottreau 1 , Shannon F Baker 1 , Herbert L DuPont 1 2 3 4 , Kevin W Garey [[dagger]â ] 5 Keywords : Clostridium difficile; hepatic encephalopathy; nonabsorbable antibiotic; rifamycin;...

• Stability indicating HPTLC method for analysis of rifaximin in pharmaceutical formulations and an application to acidic degradation kinetic study

  Authors:Kalpana G. Patel, Nitesh R. Jain, and Purvi A. ShahFrom:ISRN Analytical ChemistryPeer-Reviewed

  Annual 20134,004 words Report 1460LA specific stability indicating high-performance thin-layer chromatographic method for analysis of rifaximin both as a bulk drug and in formulations was developed and validated. The method employed HPTLC aluminium...

• Acupuncture for Diarrhoea-Predominant Irritable Bowel Syndrome: A Network Meta-Analysis.

  Authors:Lingping Zhu, Yunhui Ma, Shasha Ye, and Zhiqun ShuFrom:Evidence - Based Complementary and Alternative Medicine (Vol. 2018) Peer-Reviewed

  Annual 20185,472 words Article 1310LBackground. The objective of this study was to compare the efficacy and side effects of acupuncture, sham acupuncture, and drugs in the treatment of diarrhoea-predominant irritable bowel syndrome. Methods. Randomized...

• Rifaximin (Salix) for the maintenance

  From:Formulary (Vol. 44, Issue 10) Peer-Reviewed

  Oct. 200910 words Brief article Rifaximin (Salix) for the maintenance of remission of hepatic encephalopathy...

• Update on Treatment of Clostridioides difficile Infection.

  Authors:Janice M. Cho, Darrell S. Pardi, and Sahil KhannaFrom:Mayo Clinic Proceedings (Vol. 95, Issue 4) Peer-Reviewed

  Apr. 20206,717 words Article 1840LAbstract Clostridioides difficile infection (CD1) is the leading cause of health care--associated infections in the United States. The increasing incidence and recurrence rates of CDI together with its associated...

• Enteric etiological surveillance in acute diarrhea stool of United States Military Personnel on deployment in Thailand, 2013-2017.

  Authors:Woradee Lurchachaiwong, Oralak Serichantalergs, Paphavee Lertsethtakarn, Nattaya Ruamsap, Apichai Srijan, Wirote Oransathid, et al.From:Gut Pathogens (Vol. 12, Issue 1) Peer-Reviewed

  Apr. 9, 20203,553 words Article 1530LBackground Diarrhea remains a major public health problem for both civilian and military populations. This study describes the prevalence of acute diarrheal illness etiological agents, their antibiotic resistance...

• Uncomplicated diverticular disease: innate and adaptive immunity in human gut mucosa before and after Rifaximin

  Authors:Rossella Cianci, Simona Frosali, Danilo Pagliari, Paola Cesaro, Lucio Petruzziello, Fabio Casciano, et al.From:Journal of Immunology Research (Vol. 2014) Peer-Reviewed

  Annual 20145,018 words Report 1330LBackground/Aim. Uncomplicated diverticular disease (UDD) is a frequent condition in adults. The pathogenesis of symptoms remains unknown. Bacteria are able to interact with Toll-like receptors (TLRs) and to induce...

• News in brief

  From:Expert Review of Gastroenterology & Hepatology (Vol. 6, Issue 3) Peer-Reviewed

  June 2012523 words Report 1220LResearchers have found that rifaximin and lubiprostone are the safest drug choices for the treatment of patients with irritable bowel syndrome. Researchers from the Cedars-Sinai Medical Center (CA, USA) have...

• Rifaximin

  From:Formulary (Vol. 44, Issue 9) Peer-Reviewed

  Sept. 200934 words Brief article 980LRifaximin. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: A randomized trial. Ann Intern Med. 2006;145:557-563....

• Chronic Liver Failure.

  Author:Deanna T. AllisonFrom:MedSurg Nursing (Vol. 28, Issue 6) Peer-Reviewed

  Nov-Dec 20191,026 words Article 1450LThe Medical-Surgical Nursing Certification Board (MSNCB[TM]) is a professional organization whose mission is to validate excellence in medical-surgical nursing and care coordination and transition management. MSNCB...

• The Diagnosis Performance of the TCM Syndromes of Irritable Bowel Syndrome by Gastroenterologists Based on Modified Simple Criteria Compared to TCM Practitioners: A Prospective, Multicenter Preliminary Study.

  Authors:Jun Song, Ling Yang, Shuai Su, Mei-Yu Piao, Bao-Li Li, Lie-Xin Liang, et al.From:Evidence - Based Complementary and Alternative Medicine (Vol. 2020) Peer-Reviewed

  July 31, 20204,789 words Clinical report 1460LPurpose. Traditional Chinese medicine (TCM) including Chinese patent medicine has been widely used to treat irritable bowel syndrome (IBS). Syndrome differentiation is the essence of TCM. However, the diagnostic ability...

• Portal Vein Thrombosis after the Consumption of Date Seed Powder: A Case Study.

  Authors:Mohammad Ali Zakeri, Mohammad Hossein Bagheripour, Marcello Iriti, and Mahlagha DehghanFrom:Case Reports in Medicine (Vol. 2021) Peer-Reviewed

  Apr. 19, 20213,498 words Case study 1310LDate seeds can be used as ingredients to enhance the nutritional value of some functional foods for human consumption as well as additives in pharmaceutical and cosmetic industries. However, there are no reports on the...

• Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance

  Authors:Dhara Shah, Minh-Duc Dang, Rodrigo Hasbun, Hoonmo L Koo, Zhi-Dong Jiang, Herbert L DuPont, et al.From:Expert Review of Anti-infective Therapy (Vol. 8, Issue 5) Peer-Reviewed

  May 20106,865 words Report 1270LAuthor(s): Dhara Shah 1 2 , Minh-Duc Dang 1 , Rodrigo Hasbun 3 , Hoonmo L Koo 2 4 5 , Zhi-Dong Jiang 2 4 , Herbert L DuPont 1 2 3 4 5 , Kevin W Garey [[dagger]â ] 6 Keywords : Clostridium difficile;...

• Xlfaxan

  From:Formulary (Vol. 45, Issue 4) Peer-Reviewed

  Apr. 201022 words Brief article 1360LRifaximin (Xifaxan, Salix) for the reduction in the risk of the recurrence of overt hepatic encephalopathy in patients with advanced liver disease....

• The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.

  Authors:Nina Kimer, Mads Meldgaard, Ole Hamberg, Thit Mynster Kronborg, Allan M. Lund, Holger Jon Møller, et al.From:PLoS ONE (Vol. 17, Issue 3) Peer-Reviewed

  Mar. 14, 20225,259 words Report 1460LBackground and aims Alcoholic hepatitis (AH) is characterized by acute liver failure, neurocognitive impairment and renal failure. Severe inflammatory reactions are also known to occur in AH. Inflammation and bacterial...

• Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.

  Authors:Charlotte W. Wernberg, Ove B. Schaffalitzky de Muckadell, Hendrik Vilstrup, Mette M. Lauridsen, and Pavel StrnadFrom:PLoS ONE (Vol. 14, Issue 12) Peer-Reviewed

  Dec. 12, 20194,592 words Article 1380LBackground and aim Predicting overt hepatic encephalopathy (OHE) is important because the condition is frequent, often requires hospitalization and is potentially preventable. The risk of OHE is related to pre-existing...

• Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients

  Authors:Ji Young Chang, Seong-Eun Kim, Tae Hun Kim, So-Youn Woo, Min Sun Ryu, Yang-Hee Joo, et al.From:PLoS ONE (Vol. 12, Issue 10) Peer-Reviewed

  Oct. 5, 20174,873 words Report 1550LObjectives Rifaximin, a poorly absorbed antibiotics, has gut-specific therapeutic effects. Although frequently prescribed to manipulate intestinal luminal bacterial population in various diseases, the possible...

• An Oral Formulation of the Probiotic, Bacillus subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy.

  Authors:Sayed Yossef, Frances Clark, Sarah S. Bubeck, John Abernethy, Thomas Bayne, Kiran Krishnan, et al.From:Evidence - Based Complementary and Alternative Medicine (Vol. 2020) Peer-Reviewed

  July 31, 20204,530 words Clinical report 1300LBackground. Hepatic encephalopathy often results in high blood ammonia levels because of inefficient ammonia processing by the liver. Lactulose treatment promotes the growth of urease-producing gut bacteria and a reduced...

• Rifaximin induced Stevens-Johnson syndrome in a patient of acute on chronic liver failure

  Authors:Cyriac Philips, Chetan Kalal, Amrish Sahney, and K N. KumarFrom:Oncology, Gastroenterology and Hepatology Reports (Vol. 4, Issue 2) Peer-Reviewed

  July-December 20152,415 words Clinical report 1550LByline: Cyriac. Philips, Chetan. Kalal, Amrish. Sahney, K N. Kumar Stevens-Johnson Syndrome (SJS) forms part of a spectrum of severe adverse cutaneous reactions that can eventually culminate into toxic epidermal...

• Rifaximin may prevent multiple recurrences of CDAD

  From:Formulary (Vol. 42, Issue 1) Peer-Reviewed

  Jan. 2007409 words Clinical report 1490LData indicate that oral rifaximin can prevent recurrences of Clostridium difficile-associated diarrhea (CDAD) in patients treated previously with vancomycin, said presenters at the American College of Gastroenterology...